TD Cowen Downgrades Bio-Techne to Hold, Raises Price Target to $73
TD Cowen analyst Kyle Boucher downgrades Bio-Techne (NASDAQ: TECH ) from Buy to Hold and raises the price target from $65 to $73.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
TD Cowen analyst Kyle Boucher downgrades Bio-Techne (NASDAQ: TECH ) from Buy to Hold and raises the price target from $65 to $73.